SB 9200 treatment results in transient reduction of WHcAg expression and inflammation in liver.
- Kyle E. Korolowicz (3072084)
- Radhakrishnan P. Iyer (1383096)
- Stefanie Czerwinski (3072075)
- Manasa Suresh (3072072)
- Junming Yang (793622)
- Seetharamaiyer Padmanabhan (3010053)
- Anjaneyulu Sheri (299560)
- Rajendra K. Pandey (3072078)
- Jeffrey Skell (3072066)
- Judith K. Marquis (3072081)
- Bhaskar V. Kallakury (3072063)
- Robin D. Tucker (3072069)
- Stephan Menne (793626)
Publication date
August 2016
DOIAbstract
<p>Changes in mean immunohistochemistry (IHC) score for cytoplasmic WHcAg expression in liver (<b>top panels</b>) and liver histology score for portal and lobular sinusoidal hepatitis (<b>bottom panels</b>) in response to SB 9200 treatment at a low (<b>A, C</b>) or high dose (<b>B, D</b>). Changes in mean serum WHV DNA relative to T<sub>0</sub> is plotted on the left y-axis. Error bars represent the standard error of the mean.</p
Add to ORKG